VJHemOnc is committed to improving our service to you

ISA 2020 | The value of screening biopsies in AL & ATTR amyloidosis

VJHemOnc is committed to improving our service to you

Oliver Charles Cohen

Oliver Charles Cohen, MD, University College London Hospitals NHS Foundation Trust, London, UK, talks on the value of screening biopsies in light-chain (AL) and transthyretin (ATTR) amyloidosis. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter